Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients

Clinical Immunology

Volumn 131, Issue 1, 2009, Pages 84-91

  Marciano, Renato ^a,b   D'Annunzio, Giuseppe ^a   Minuto, Nicola ^a   Pasquali, Lorenzo ^a   Santamaria, Andrea ^a   Di Duca, Marco ^a   Ravazzolo, Roberto ^a,b   Lorini, Renata ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmunity; Osteopontin; Polymorphisms; Type 1 diabetes

Indexed keywords

OSTEOPONTIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SPP1 GENE;

ADOLESCENT; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; MEMBRANE GLYCOPROTEINS; OSTEOPONTIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 63249093583     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.11.004     Document Type: Article

References (43)

1. Bottini N., Vang T., Cucca F., and Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18 (2006) 207-213
2. Gorodezky C., Alaez C., Murguia A., Rodriguez A., Balladares S., Vazquez M., Flores H., and Robles C. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun. Rev. 5 (2006) 187-194
3. Serrano N.C., Millan P., and Paez M.C. Non-HLA associations with autoimmune diseases. Autoimmun. Rev. 5 (2006) 209-214
4. Smyth D.J., Howson J.M., Payne F., Maier L.M., Bailey R., Holland K., Lowe C.E., Cooper J.D., Hulme J.S., Vella A., Dahlman I., Lam A.C., Nutland S., Walker N.M., Twells R.C., and Todd J.A. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med. Genet. 7 (2006) 20
5. Daneman D. Type 1 diabetes. Lancet 367 (2006) 847-858
6. Sorensen E.S., Hojrup P., and Petersen T.E. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4 (1995) 2040-2049
7. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482
8. Fisher L.W., and Fedarko N.S. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect. Tissue Res. 44 Suppl. 1 (2003) 33-40
9. Aspord C., Rome S., and Thivolet C. Early events in islets and pancreatic lymph nodes in autoimmune diabetes. J. Autoimmun. 23 (2004) 27-35
10. Katakam A.K., Chipitsyna G., Gong Q., Vancha A.R., Gabbeta J., and Arafat H.A. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production. J. Endocrinol. 187 (2005) 237-247
11. Lampe M.A., Patarca R., Iregui M.V., and Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol. 147 (1991) 2902-2906
12. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., and Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287 (2000) 860-864
13. Yumoto K., Ishijima M., Rittling S.R., Tsuji K., Tsuchiya Y., Kon S., Nifuji A., Uede T., Denhardt D.T., and Noda M. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4556-4561
14. Chabas D., Baranzini S.E., Mitchell D., Bernard C.C., Rittling S.R., Denhardt D.T., Sobel R.A., Lock C., Karpuj M., Pedotti R., Heller R., Oksenberg J.R., and Steinman L. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001) 1731-1735
15. Iizuka J., Katagiri Y., Tada N., Murakami M., Ikeda T., Sato M., Hirokawa K., Okada S., Hatano M., Tokuhisa T., and Uede T. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab. Invest. 78 (1998) 1523-1533
16. Patarca R., Wei F.Y., Singh P., Morasso M.I., and Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease. J. Exp. Med. 172 (1990) 1177-1183
17. Fierabracci A., Biro P.A., Yiangou Y., Mennuni C., Luzzago A., Ludvigsson J., Cortese R., and Bottazzo G.F. Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. Vaccine 18 (1999) 342-354
18. Giacopelli F., Marciano R., Pistorio A., Catarsi P., Canini S., Karsenty G., and Ravazzolo R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 20 (2004) 87-96
19. Chiocchetti A., Indelicato M., Bensi T., Mesturini R., Giordano M., Sametti S., Castelli L., Bottarel F., Mazzarino M.C., Garbarini L., Giacopelli F., Valesini G., Santoro C., Dianzani I., Ramenghi U., and Dianzani U. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103 (2004) 1376-1382
20. D'Alfonso S., Barizzone N., Giordano M., Chiocchetti A., Magnani C., Castelli L., Indelicato M., Giacopelli F., Marchini M., Scorza R., Danieli M.G., Cappelli M., Migliaresi S., Bigliardo B., Sabbadini M.G., Baldissera E., Galeazzi M., Sebastiani G.D., Minisola G., Ravazzolo R., Dianzani U., and Momigliano-Richiardi P. Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 539-547
21. Marciano R., Giacopelli F., Divizia M.T., Gattorno M., Felici E., Pistorio A., Martini A., Ravazzolo R., and Picco P. A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis. Ann. Rheum. Dis. 65 (2006) 662-665
22. Caillier S., Barcellos L.F., Baranzini S.E., Swerdlin A., Lincoln R.R., Steinman L., Martin E., Haines J.L., Pericak-Vance M., Hauser S.L., and Oksenberg J.R. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 4 (2003) 312-315
23. Williams A.J., Norcross A.J., Dix R.J., Gillespie K.M., Gale E.A., and Bingley P.J. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia 46 (2003) 1354-1356
24. Lorini R., Alibrandi A., Vitali L., Klersy C., Martinetti M., Betterle C., d'Annunzio G., and Bonifacio E. Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study. Diabetes Care 24 (2001) 1210-1216
25. Lorini R., Avanzini M.A., Lenta E., Cotellessa M., De Giacomo C., and d'Annunzio G. Antibodies to tissue transglutaminase C in newly diagnosed and long-standing type I diabetes mellitus. Diabetologia 43 (2000) 815-816
26. Lorini R., Scaramuzza A., Vitali L., d'Annunzio G., Avanzini M.A., De Giacomo C., and Severi F. Clinical aspects of coeliac disease in children with insulin-dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 9 Suppl. 1 (1996) 101-111
27. Lorini R., d'Annunzio G., Vitali L., and Scaramuzza A. IDDM and autoimmune thyroid disease in the pediatric age group. J. Pediatr. Endocrinol. Metab. 9 Suppl. 1 (1996) 89-94
28. Hoogendoorn B., Owen M.J., Oefner P.J., Williams N., Austin J., and O'Donovan M.C. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum. Genet. 104 (1999) 89-93
29. Kim M.S., and Polychronakos C. Immunogenetics of type 1 diabetes. Horm. Res. 64 (2005) 180-188
30. Rudert W.A., and Trucco M. To be DR8 or not to be DQ8, that is the question. Pediatr. Diabetes 8 (2007) 1-4
31. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40 (1987) 1-14
32. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S.F., Simon J.C., and Weiss J.M. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 106 (2005) 946-955
33. Jansson M., Panoutsakopoulou V., Baker J., Klein L., and Cantor H. Cutting edge: attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 168 (2002) 2096-2099
34. Chung J.W., Kim M.S., Piao Z.H., Jeong M., Yoon S.R., Shin N., Kim S.Y., Hwang E.S., Yang Y., Lee Y.H., Kim Y.S., and Choi I. Osteopontin promotes the development of natural killer cells from hematopoietic stem cells. Stem Cells 26 (2008) 2114-2123
35. Shinohara M.L., Kim J.H., Garcia V.A., and Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29 (2008) 68-78
36. Giacopelli F., Rosatto N., Divizia M.T., Cusano R., Caridi G., and Ravazzolo R. The first intron of the human osteopontin gene contains a C/EBP-beta-responsive enhancer. Gene Expr. 11 (2003) 95-104
37. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 28 (2007) 1-6
38. Cucca F., Goy J.V., Kawaguchi Y., Esposito L., Merriman M.E., Wilson A.J., Cordell H.J., Bain S.C., and Todd J.A. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat. Genet. 19 (1998) 301-302
39. Carle F., Gesuita R., Bruno G., Coppa G.V., Falorni A., Lorini R., Martinucci M.E., Pozzilli P., Prisco F., Songini M., Tenconi M.T., and Cherubini V. Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study. Diabetes Care 27 (2004) 2790-2796
40. Gale E.A., and Gillespie K.M. Diabetes and gender. Diabetologia 44 (2001) 3-15
41. Kahles H., Ramos-Lopez E., Lange B., Zwermann O., Reincke M., and Badenhoop K. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol. 153 (2005) 895-899
42. Kimpimaki T., Kulmala P., Savola K., Kupila A., Korhonen S., Simell T., Ilonen J., Simell O., and Knip M. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J. Clin. Endocrinol. Metab. 87 (2002) 4572-4579
43. Kupila A., Keskinen P., Simell T., Erkkila S., Arvilommi P., Korhonen S., Kimpimaki T., Sjoroos M., Ronkainen M., Ilonen J., Knip M., and Simell O. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 51 (2002) 646-651